GHIT Fund Product Development Platform - Request for Proposals, 2019

Deadline for 'intent to apply' applications: 17 Dec 2019 10:00 (UK+9)

Deadline for full proposal applications: 24 Jan 2020 10:00 (UK+9)

GHIT Fund Background

Over a billion people in the developing world suffer from infectious diseases, creating a need for new low-cost, high-impact health technologies. Response to this need in recent years has resulted in the development of new products, many of which have been the result of partnerships between pharmaceutical companies, academic and research institutions, and Product Development Partnerships (PDPs). These partnerships have proven to be an effective method for developing impactful global health technologies. The Global Health Innovative Technology Fund (GHIT Fund) is a non-profit organization focused on promoting the discovery and development of new health technologies, including drugs, vaccines, and diagnostics for infectious diseases prevalent in developing countries. The GHIT Fund aims to advance Japan’s wealth of health technology innovation for the discovery and development of new technologies for developing world patients and populations affected by infectious disease. To this end, the GHIT Fund will catalyze R&D partnerships between Japanese and non-Japanese organizations and support these partnerships through GHIT Fund investments.

Funding Opportunity

The Product Development Platform (PD) is one of four GHIT Fund investment platforms. The GHIT Fund is pleased to announce a product development investment opportunity for the development of new drugs, vaccines, or diagnostics for infectious diseases that are prevalent in the developing world.

Proposed collaboration projects should be no more than two years in duration and focus on R&D activities within the following development stages, including:

• Lead optimization

• Preclinical Development (in vivo studies, formulation development, chemistry and process validation)

• Clinical Development (Phase 1, 2, or 3 studies, manufacturing scale-up)

• Activities to support licensure and WHO prequalification PD Request for Proposal 2

Please note that a project that does not cover development stages within the scope of Product Development Platform as described above will not be considered eligible. Please ensure that development stages of your project fall into the scope of this platform.

Investment Eligibility

GHIT Fund investments can be awarded to existing or new partnerships between Japanese and nonJapanese organizations. Each partner should have a history of health intervention R&D and have the expertise to know which projects represent potentially substantial additions to the field. The GHIT Fund requires each investment to have at least one eligible Japanese and one eligible non-Japanese organization as partners in order to be considered eligible.

For more details, or to apply, visit the call webpage.